← All organizations
Highest phase reached
Phase 4
Acquired by Eli Lilly on Jan 10, 2020
Timeline
2010s
- Jul 1, 2010
Dermira, Inc.— Founded
- Jun 28, 2018
glycopyrronium— NDA Secondary Org
2020s
- Jan 10, 2020
Eli Lilly— Acquired By
Drugs by trial phase (7 distinct, 26 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (44)
- NCT06906497CollaboratorPhase 4Jul 2, 2025
- NCT05559359CollaboratorPhase 3Oct 18, 2022
- NCT04392154Lead sponsorPhase 3Jun 30, 2020
- NCT04392154Study directorPhase 3Jun 30, 2020
- NCT04250337Study directorPhase 3Jan 31, 2020
- NCT04250350Lead sponsorPhase 3Jan 31, 2020
- NCT04250350Study directorPhase 3Jan 31, 2020
- NCT04250337Lead sponsorPhase 3Jan 31, 2020
- NCT04178967Lead sponsorPhase 3Nov 8, 2019
- NCT04178967Study directorPhase 3Nov 8, 2019
- NCT04146363Lead sponsorPhase 3Oct 8, 2019
- NCT04146363Study directorPhase 3Oct 8, 2019
- NCT03880266Lead sponsorPhase 2Feb 22, 2019
- NCT03880266Study directorPhase 2Feb 22, 2019
- NCT03443024Lead sponsorPhase 2Jan 30, 2018
Details
- Founded
- Menlo Park, CA, US Jul 1, 2010
- Last known activity
- Jul 2, 2025